4//SEC Filing
HYPERION THERAPEUTICS INC 4
Accession 0001437749-15-004008
CIK 0001386858operating
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 6:32 PM ET
Size
7.3 KB
Accession
0001437749-15-004008
Insider Transaction Report
Form 4
Scharschmidt Bruce Frederick
SVP & Chief Medical Officer
Transactions
- Sale
Common Stock
2015-02-27$29.79/sh−24,996$744,631→ 29,252 total(indirect: By The Bruce Frederick Scharschimdt and Peggy Sue) - Sale
Common Stock
2015-02-27$30.43/sh−4,804$146,186→ 24,448 total(indirect: By Trust)
Holdings
- 97,471
Common Stock
Footnotes (2)
- [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.27-$30.26. The reporting person undertakes to provide Hyperion Therapeutics, Inc, any security holder of Hyperion Therapeutics, Inc or the staff of the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- [F2]The price reported in column 4 is weighted average price. These shares were sold in multiple transactions ranging from $30.26-$30.59, inclusive.
Documents
Issuer
HYPERION THERAPEUTICS INC
CIK 0001386858
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001386858
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 6:32 PM ET
- Size
- 7.3 KB